Membership in the TTS Global Initiative is free, and offers un-matched value for biotech innovation, tech transfer, IP, licenising and venture professionals.
How will membership benefit you?
Increasingly there is a dearth of information, and very often a lack of access to the required expertise. Organisations which seek to succeed in transfering and developing their technologies understand that this means following best practices and learning from the failures of others rather than repeating them, securing access to expert advice, and ensuring that their teams have access to the networks, knowledge, contacts and expertise needed to meet their objectives.
The TTS Global Initiative is a growing international network established with the sole mission of aiding the progression of commercialisation in biotechnology innovation and the development of the global BioEconomy and its key hotspots. We work with leading Governments, regions, multinational corporations, investors and of course the innovators and their universities, institutes and offices to establish not only a focal point and platform for networking but importantly the source for connecting.
It is our mission to provide links and resources to our members that enable them to solve real-life challenges which may include strategy, business development, protection of IPR, source grants or finance, and ultimately form a business co-development partnership / collaboration. TTS Ltd. aims to deliver a unique source of stakeholder contacts and practices to ensure the instigation of business relationship, the management of those expectations and ultimately the business benefits of commercialisation.
TTS Ltd. helps to achieve this through the TTS Global Initiative by bringing together all key relevant stakeholders; technology transfer officers, BioRegion executives, financiers, policy experts, business development & licensing executives and lawyers to talk about the many and complex issues they face and the solutions they have developed to circumnavigate the very real challenges that lie ahead.
To become a part of the TTS Global Initiative - join here
September 27, 2012
Chris Austin, Director, NIH National Center for Advancing Translational Science (NCATS) to deliver a keynote presentation at TTS North America 2012.
September 24, 2012
We are pleased to confirm the Steven Tregay, CEO of Forma Therapeutics, will deliver a keynote presentation at the TTS North America 2012.
Founded in 2008 and… more
June 13, 2012
The Licensing Executive Society (LES) Britain & Ireland has officially become a Partner of the Global Tech Transfer Initiative, and will be present at the TTS… more
December 4, 2013